Mechanisms of Gastrointestinal Toxicity of Nonsteroidal Anti-Inflammatory Drugs

References

• Rainsford K D. Side effects of anti-inflammatory drugs, K D Rainsford, G P Velo. MTP Press, Lancaster 1987; Vol. 2: 3–26
   Google Scholar
• Rainsford K D, Fox S A, Osborne D J. Advances in prostaglandins, leukotrienes and lipoxins, M J Bailey. Plenum Press, New York 1985; 639–653
   Google Scholar
• Whittle B JR, Vane J R. A biochemical basis for the gastrointestinal toxicity of non-steroid anti-rheumatoid drugs. Arch Toxicol 1984, suppl 7: 315–322
   Google Scholar
• Rainsford K D. Eidosanoids and the gastrointestinal tract, K Hillier. MTP Press, Lancaster 1988; 111–128
   Google Scholar
• Garner A, Allen A. Gastroduodenal mucosal defense mechanisms and the action of non-steroidal anti-inflammatory agents. Scand J Gastroenterol 1987; 22(suppl 127)29–34
   PubMed Web of Science ®Google Scholar
• Takagi K, Kawahiwa K. Effects of some antiinflammatory drugs on capillary permeability of the gastric mucosa in the rat. Jpn J Pharmacol 1969; 19: 431–437
   PubMedGoogle Scholar
• Harding R K, Morris G P. Scanning electron microscopy/1976. Part V. Proceedings of the workshop on advances in biomedical applications of the SEM. IIT Research Institute, Chicago, III 1976; 253–260
   Google Scholar
• Robins P G. Ultrastructural observations on the pathogenesis of aspirin-induced gastric erosions. Br J Exp Pathol 1980; 61: 497–504
   PubMedGoogle Scholar
• Gerkens J F, Shand D G, Flexner C, Nies A S, Oates J A, Data J L. Effect of indomethacin and aspirin on gastric blood-flow and acid secretion. J Pharmacol Exp Ther 1977; 203: 646–652
   PubMed Web of Science ®Google Scholar
• Peskar B M, Kleien A, Pyras F, Muller M K. Gastrointestinal toxicity. Role of prostaglandins and leukotrienes. Med Toxicol 1986; 1(suppl 1)39–43
   PubMedGoogle Scholar
• Rainsford K D. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice. Agents Actions 1987; 21: 316–319
   PubMedGoogle Scholar
• Ligumsky M, Golanska E M, Hansen D G, Kauff-Man G L. Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rat. Gastroenterology 1984; 84: 756–761
   Web of Science ®Google Scholar
• Whittle B JR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94–98
   PubMed Web of Science ®Google Scholar
• Rainsford K D. Comparative irritancy of oxaprozin on the gastrointestinal tract of rats and mice- relationship to drug uptake and effects in vivo on eicosanoid metabolism. Aliment Pharmacol Ther 1988; 2: 439–450
   PubMed Web of Science ®Google Scholar
• Redfern J S, Lee E, Feldman M. Effect of indomethacin on gastric-mucosal prostaglandins in humans-correlation with mucosal damage. Gastroenterology 1987; 92: 969–977
   PubMed Web of Science ®Google Scholar
• Ligumsky M, Grossman M I, Kauffman G L, Jr. Endogenous gastric-mucosal prostaglandins-their role in mucosal integrity. Am J Physiol 1982; 242: G337–G341
   Google Scholar
• Rainsford K D. Comparison of the gastric ulcerogenic activity of new non-steroid anti-inflammatory drugs in stressed rats. Br J Pharmacol 1981; 73: 79c–80c
   Web of Science ®Google Scholar
• Tavares I A, Collins P O, Bennett A. Aliment Pharmacol Ther 1987; 1: 617–625
   PubMedGoogle Scholar
• Rainsford K D. Gastric ulcerogenicity of non-steroidal anti-inflammatory drugs in mice with mucosa sensitized by cholinomimetic treatment. J Pharm Pharmacol 1987; 39: 669–672
   PubMed Web of Science ®Google Scholar
• Carty T J, Stevens J S, Lombardino J G, Parry M J, Randall M J. Piroxicam, a structurally novel antiinflammatory compound-mode of prostaglandin synthesis inhibition. Prostaglandins 1980; 19: 671–682
   PubMed Web of Science ®Google Scholar
• Flower R. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 1974; 26: 33–67
   PubMed Web of Science ®Google Scholar
• Wiseman E H. Anti-inflammatory and anti-rheumatic drugs, K D Rainsford, 1985; Vol. II: 209–248
   Google Scholar
• McCormack K, Brune K. Classical absorption theory and the development of gastric-mucosal damage associated with the non-steroidal anti-inflammatory drugs. Arch Toxicol 1987; 60: 261–269
   PubMed Web of Science ®Google Scholar
• Krupinska J, Sobanski H V, Piotrowicz J, Cibo B, Mazur J. Antioxidants as agents reducing the toxicity of indomethacin. Acta Biol Med Ger 1980; 39: 717–721
   PubMedGoogle Scholar
• Shriver D A, Thompson J W, Scott C K, Moore L E, Woolf G, Mack V J. The gastric antisecretory and anti-ulcer activity of MK-447, an enhancer of prostaglandin synthesis. Life Sci 1980; 27: 2483–2487
   PubMed Web of Science ®Google Scholar
• van Kolfschoten A A, Hagelen F, van Noordwijk J. Butyl hydroxytoluene antagonizes the gastric toxicity but not the pharmacological activity of acetyl-salicylic-acid in rats. Naunyn-Schmiedebergs Arch Pharmacol 1984; 325: 283–285
   PubMedGoogle Scholar
• Rainsford K D. Side effects of anti-inflammatory/analgesic drugs, K D Rainsford, G P Velo. Raven Press, New York 1984; 51–64
   Google Scholar
• Rainsford K D. Microvascular injury during gastric-mucosal damage by anti-inflammatory drugs in pigs and rats. Agents Actions 1983; 13: 457–460
   PubMedGoogle Scholar
• Young R N, Zamboni R., US Patent 4, 661, 499, 29 Apr., 1987, Chem Abstr 1987, 107, 39646t
   Google Scholar
• Young R N, Zamboni R, Leger S. Eur Pat Appl EP 219, 307. Chem Abstr 1987; 107: 39645s
   Google Scholar
• Rogers C, Brown A, Szabo S. Gastric mucosal protection by new aryl sulfhydryl drugs. Dig Dis Sci 1985; 33: 324–329
   Google Scholar
• Evangelista S, Maggi C A, Meli A. The effect of levamisole on gastric ulcers induced in the rat by anti-inflammatory and necrotizing agents. J Pharm Pharmacol 1984; 36: 270–272
   PubMed Web of Science ®Google Scholar
• Ghanayem B I, Ahmed A E, Boor P J. Acetyl salicylic acid-induced gastric mucosal lesions-no proof of gastric glutathione. Res Commun Chem Pathol Pharmacol 1984; 45: 153–156
   PubMedGoogle Scholar
• Rainsford K D, Swann B P, Bannister J V, Bannister W H. The biochemistry of active oxygen. Elsevier, New York 1984; 105–127
   Google Scholar
• Rainsford K D. Handbook of prostaglandins and related eicosanoids, C P Curtis-Prior. Churchill-Livingstone, London 1988; 52–68
   Google Scholar
• Peskar B M, Hoppe U, Lange K, Peskar B A. Effects of non-steroidal anti-inflammatory drugs on rat gastric-mucosal leukotriene C-4 and prostanoid release-relation to ethanol-induced injury. Br J Pharmacol 1988; 93: 937–943
   PubMed Web of Science ®Google Scholar
• Rainsford K D, Willis C M. Relationship of gastric-mucosal damage induced on pigs by anti-inflammatory drugs to their effects on prostaglandin production. Dig Dis Sci 1982; 27: 624–635
   PubMed Web of Science ®Google Scholar
• Rainsford K D, Fox S A, Osborne D J. Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa. Relationship to drug uptake. Scand J Gastroenterol 1984; 19(suppl 101)55–68
   Google Scholar
• Pendleton R G, Stavorski J R. Evidence for differing leukotriene receptors in gastric mucosa. Eur J Pharmacol 1986; 125: 297–299
   PubMed Web of Science ®Google Scholar
• Granger D N, Rutili G, McCord J M. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981; 81: 22–29
   PubMed Web of Science ®Google Scholar
• Salvati P, Whittle B JR. Investigation of the vascular actions of arachidonate lipoxygenase and cyclo-oxy-genase products on the isolated perfused stomach of rat and rabbit. Prostaglandins 1981; 22: 141–156
   PubMedGoogle Scholar
• Glarborg Jorgensen T, Weis-Fogh U S, Nielsen H H, Olesen H P. Salicylate-induced and aspirin-induced uncoupling of oxidate-phosphorylation in mitochondria isolated from mucosal membrane of stomach. Scand J Clin Lab Invest 1976; 36: 649–654
   PubMed Web of Science ®Google Scholar
• Glarborg Jorgensen T, Weis-Fogh U S, Olesen H P. Influence of acetylsalicylic acid (aspirin) on gastric mucosal content of energy-rich phosphate bonds. Scand J Clin Lab Invest 1976; 36: 771–777
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Williams P, Smethurst P, Peters T J, Levi A J. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986; 27: 1292–1297
   PubMed Web of Science ®Google Scholar
• Jenkins R T, Rooney P J, Jones D B, Bienenstock J, Goodacre R L. Increased intestinal permeability in patients with rheumatoid arthritis. A side-effect of oral nonsteroidal anti-inflammatory drug therapy. Br J Rheumatol 1987; 26: 103–107
   PubMedGoogle Scholar
• Duggan D A, Cook P G, Bauer B J, Dagle G E. Indomethacin-induced intestinal lesions in the rat. Toxicol Appl Pharmacol 1970; 17: 615–624
   PubMed Web of Science ®Google Scholar
• Shriver D A, Dove P A, White C B, Sandor A, Rosenthale M E. Profile of gastrointestinal toxicity of aspirin, indomethacin, oxaprozin, phenylbutazone and fentiazac and Lewis normal rats. Toxicol Appl Pharmacol 1977; 42: 75–83
   PubMed Web of Science ®Google Scholar
• Rainsford K D. Gastroenterology: New trends in pathophysiology and therapy of the large bowel, S F Phillips, L Barbara, R D Paolette. Elsevier/ North Holland, Amsterdam 1983; 207–220
   Google Scholar
• Duggan D E, Hooke K F, Noll R M, Kavan K C. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol 1975; 25: 1749–1754
   Web of Science ®Google Scholar
• Brune K, Dietzel K, Nurnberg B, Schneider H T. Recent insight into the mechanism of gastrointestinal-tract ulceration. Scand J Gastroenterol 1987; 22(suppl 65)135–140
   PubMedGoogle Scholar
• Del Soldato P, Meli A. Further investigations on indomethacin and intestinal ulcers in rat. Toxicology 1978; 9: 69–74
   PubMed Web of Science ®Google Scholar
• Kent T H, Cardelli R M, Stamler F W. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol 1969; 54: 237–249
   PubMed Web of Science ®Google Scholar
• Robet A, Asano T. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins 1977; 14: 333–341
   PubMedGoogle Scholar
• Rainsford K D. Mucosal lesions induced in the rat intestinal tract by the anti-inflammatory drug, 104–41,770, a week inhibitor of prostaglandin synthesis, contrasted with those from the potent prostaglandin inhibitor, indomethaxin. Toxicol Pathol 1988; 16: 366–375
   PubMed Web of Science ®Google Scholar
• Fang W-F, Broughton A, Jacobson E D. Indomethacin-induced intestinal inflammation. Am J Dig Dis 1977; 22: 749–760
   PubMedGoogle Scholar
• Billingham M EJ, Tucker M J. Correlation between the rise in acute phase proteins and histological evidence of ulceration in the rat following indomethacin treatment. Br J Pharmacol 1979; 67: 450p–451p
   Web of Science ®Google Scholar
• Smith P L, Blumberg J B, Stoff J S, Field M. Antisecretory effects of indomethacin on rabbit ileal mucosa in vitro. Gastroenterology 1981; 80: 356–365
   PubMed Web of Science ®Google Scholar
• Proctor K G. Differential effect of cytooxygenase inhibitors on absorptive hyperemia. Am J Physiol 1985; 249: H755–762
   Google Scholar
• Nakanishi K, Masad M, Nadai T. Effect of nonsteroidal anti-inflammatory drugs on the absorption of macromolecular drugs in rat rectum. Chem Pharm Bull 1986; 34: 2628–2631
   PubMed Web of Science ®Google Scholar
• Karlstrom L, Hansson G, Jodal M, Lundgren O. Influence of sodium deoxycholate on morphology, net fluid transport and mobility in the small intestine of the rat. Acta Physiol Scand 1987; 130: 273–283
   PubMedGoogle Scholar
• Siurala M, Julkunen H, Toivonen S, et al. Digestive tract in collagen diseases. Acta Med Scand 1965; 178: 13–25
   PubMedGoogle Scholar
• Haslock I, Wright V. Arthritis and intestinal diseases. J R Coll Physicians Lond 1974; 8: 154–162
   PubMedGoogle Scholar
• Meuwissen W GM, Dekker-Saeys B J, Tytgat G NJ. Ankylosing spondylitis and inflammatory bowel disease. I. Prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis. Ann Rheum Dis 1978; 37: 30–32
   PubMed Web of Science ®Google Scholar
• Enlow R W, Bias W B, Arnett F C. The spondylitis of inflammatory bowel disease-evidence for a non-HLA linked axial arthropathy. Arth Rheum 1980; 23: 1359–1365
   PubMedGoogle Scholar
• Tagesson C, Bengtsson A. Intestinal permeability to different-sized polyethyleneglycols in patients with rheumatoid arthritis. Scand J Rheumatol 1983; 12: 124–128
   PubMed Web of Science ®Google Scholar
• Bergstrom K, Havermarck G. Enzymes in intestinal mucosa from patients with rheumatoid diseases. Scand J Rheumatol 1976; 5: 29–32
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Williams P, So A, et al. Intestinal permeability and inflammation in rheumatoid arthritis. Effects of non-steroidal anti-inflammatory drugs. Lancet 1984; 2: 1171–1174
   PubMed Web of Science ®Google Scholar